4//SEC Filing
Pillar Invest Corp 4
Accession 0000899243-18-020525
CIK 0000861838other
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 5:52 PM ET
Size
13.2 KB
Accession
0000899243-18-020525
Insider Transaction Report
Form 4
Pillar Invest Corp
Director10% Owner
Transactions
- Sale
Common Stock
2018-07-19$0.88/sh−556,000$489,502→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-07-20$0.86/sh−492,567$422,672→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-07-18$0.85/sh−1,725,000$1,470,390→ 0 total(indirect: See Footnote)
Pillar Pharmaceuticals II, L.P.
Director10% Owner
Transactions
- Sale
Common Stock
2018-07-19$0.88/sh−556,000$489,502→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-07-20$0.86/sh−492,567$422,672→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-07-18$0.85/sh−1,725,000$1,470,390→ 0 total(indirect: See Footnote)
Footnotes (6)
- [F1]The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.8006-$0.9204. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F2]Shares sold by Pillar Pharmaceuticals II, L.P. ("Pillar II"). Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 7,360,451 shares of common stock of the Issuer.
- [F3]The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.8340-$0.9234. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F4]Shares sold by Pillar II. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 6,804,451 shares of common stock of the Issuer.
- [F5]The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.8300-$0.8818. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F6]Shares sold by Pillar II, of which Pillar GP is the general partner. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 6,311,884 shares of common stock of the Issuer.
Documents
Issuer
IDERA PHARMACEUTICALS, INC.
CIK 0000861838
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001534428
Filing Metadata
- Form type
- 4
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 5:52 PM ET
- Size
- 13.2 KB